Company: SION
Filing Date: 2025-11-05
Form Type: 8-K
Source: 0001628280-25-049246
Chunk: 1

Company: Sionna Therapeutics, Inc.
Filing Date: 2025-11-05
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  99.1      Press Release of Sionna Therapeutics, Inc. dated November 5, 2025.            
 ──────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                           Sionna Therapeutics, Inc.  
  Date: November 05, 2025      By:         /s/ Jennifer Fitzpatrick   
                               Name:       Jennifer Fitzpatrick       
                               Title:      Chief Legal Officer